Page 109 - NobleCon20-Book-Project
P. 109
LifeVantage Corporation
SELECTED FINANCIAL ITEMS LFVN
(in millions of USD)
CQ4 '23 CQ1 '24 CQ2 '24 CQ3 '24 LTM
Income Statement Key Items
Total Revenue 51.62 48.25 48.93 47.21 196.01
Gross Profit 40.56 38.07 38.91 37.72 155.26
Gross Margin 79% 79% 80% 80% 79%
EBIT (1.26) 1.93 2.91 2.57 6.15
EBIT Margin -2% 4% 6% 5% 3%
Net Income to Common Shareholders (0.66) 1.66 1.31 1.83 4.13
Net Margin -1% 3% 3% 4% 2%
Balance Sheet Key Items
Total Assets 62.68 61.31 60.30 61.46 61.46
Cash & Short Term Investments 17.33 17.38 16.89 14.60 14.60
% of Assets 28% 28% 28% 24% 24%
Current Assets -Total 38.66 37.80 37.65 38.82 38.82
% of Assets 62% 62% 62% 63% 63%
Total Liabilities 35.38 34.54 34.31 33.76 33.76
% of Assets 56% 56% 57% 55% 55%
Current Liabilities - Total 23.02 22.48 22.31 22.07 22.07
% of Assets 37% 37% 37% 36% 36%
Long Term Debt NA NA NA NA NA
% of Assets NM NM NM NM NM
Total Equity 27.31 26.77 25.99 27.70 27.70
% of Assets 44% 44% 43% 45% 45%
Cash Flow Statement Key Items
Net Cash Flow - Operating Activities 1.76 3.09 2.58 (0.58) 6.85
Net Cash Flow - Investing (0.54) (0.29) (0.28) (0.35) (1.46)
Net Cash Flow - Financing (2.54) (2.46) (2.74) (1.83) (9.58)
Source: Capital IQ
PRICE / VOLUME
Source: Channelchek/QuoteMedia
Noble Capital Markets' Twentieth Annual Small & Microcap Investor Conference